Phorbol ester-induced protein kinase C translocation and lysosomal enzyme release in normal and cystic fibrosis fibroblasts

The ability of the tumor-promoting phorbol ester 4β-phorbol 12β-myristate 13α-acetate (PMA) to induce protein kinase C (PKC) translocation and lysosomal enzyme release was examined in skin fibroblasts from normal subjects and from patients with cystic fibrosis (CF). As compared to normal fibroblasts...

Full description

Saved in:
Bibliographic Details
Published inFEBS letters Vol. 229; no. 1; pp. 161 - 166
Main Authors Hermelin, B., Cherqui, G., Bertrand, F., Wicek, D., Paul, A., Garcia, I., Picard, J.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 29.02.1988
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The ability of the tumor-promoting phorbol ester 4β-phorbol 12β-myristate 13α-acetate (PMA) to induce protein kinase C (PKC) translocation and lysosomal enzyme release was examined in skin fibroblasts from normal subjects and from patients with cystic fibrosis (CF). As compared to normal fibroblasts, those CF exhibited: (i) an increased sensitivity to the effect of PMA on the disappearance of PKC from cytosolic fractions as well as a greater and earlier recovery, in the membrane fraction, of the PKC activity lost in the cytosolic fraction; (ii) an earlier response to PMA for its effect on β- N-acetylglucosaminidase release. In contrast, the inactive phorbol ester 4α-phorbol 12,13-didecanoate (4αPDD) proved ineffective in inducing PKC translocation and β- N-acetylglucosaminidase release in both normal and CF fibroblasts. The data suggest a defect in the regulation of PKC activity in CF fibroblasts, which may lead to altered secretion.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-5793
1873-3468
DOI:10.1016/0014-5793(88)80818-4